Medical cannabis trial will target 20,000 UK patients
Up to 20,000 patients in the UK are to be given medical cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe.
Up to 20,000 patients in the UK are to be given medical cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe.
“This clinical trial could have a major impact and greatly improve the lives of those living with Tourette syndrome.”